Difference between revisions of "Mendel Biotechnology"
(→Collaborators: Monsanto, Bayer, BP) |
|||
| Line 14: | Line 14: | ||
Mendel's deal with Bayer involved "developing chemical products which make crops more resistant to biotic and abiotic stress factors, which in turn will stabilize yields and improve crop productivity".<ref>[http://www.mendelbio.com/newsevents/annual_report_2009.pdf Dear Shareholder], Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010</ref> | Mendel's deal with Bayer involved "developing chemical products which make crops more resistant to biotic and abiotic stress factors, which in turn will stabilize yields and improve crop productivity".<ref>[http://www.mendelbio.com/newsevents/annual_report_2009.pdf Dear Shareholder], Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010</ref> | ||
| + | |||
| + | Mendel says its program with Bayer "is a continuation of previous joint activities which focused on the elucidation of stress response mode of actions of Bayer agrochemicals like Imidacloprid and Trifloxystrobin".<ref>[http://www.mendelbio.com/strategicpartners/index.php Strategic partners], Mendel Biotechnology website, acc 8 Jul 2010</ref> | ||
==Patents owned== | ==Patents owned== | ||
Revision as of 11:21, 8 July 2010
Mendel Biotechnology, Inc. says it aims "to produce plants enhanced for food, feed, fiber, energy and aesthetic benefit without large increases in production acreage" and says it is
- dedicated to being a premier biotechnology company serving large agricultural companies with new genetic and chemical solutions and to becoming the leading seed company serving the bioenergy industry.[1]
Contents
Collaborators: Monsanto, Bayer, BP
On its website, the company names Monsanto as "Mendel's most important customer and collaborator for our technology business".[2]
In its 2008 Annual Report it lists two lines of business that were central to its growth in that year:
- a collaborative project with Monsanto on soybean yield, "the basis of which is a Mendel technology"[3]
- the establishment of "the first-ever field trials of genetically diverse Miscanthus varieties for biomass production in the United States"[4]
Mendel's 2009 Annual Report names 2009 as a "watershed year", demonstrated by two collaborative partnerships: one with Monsanto and the other with Bayer CropScience.[5]
Mendel's deal with Monsanto involved Monsanto's "initial deployment of our [Mendel's] platforms" for its "improved yield soybean".[6]
Mendel's deal with Bayer involved "developing chemical products which make crops more resistant to biotic and abiotic stress factors, which in turn will stabilize yields and improve crop productivity".[7]
Mendel says its program with Bayer "is a continuation of previous joint activities which focused on the elucidation of stress response mode of actions of Bayer agrochemicals like Imidacloprid and Trifloxystrobin".[8]
Patents owned
As at July 2010, Mendel had been granted over 20 biotechnology and GM patents, as listed on its website.[9] Its interests include developing "energy grasses" for biomass and biofuels.[10]
Affiliations
As at June 2010, Mendel's "strategic partners" are:[11]
- Monsanto. Mendel calls Monsanto its "most important customer and collaborator for our technology business".[12]
- BP
- Bayer CropScience
- Selecta Klemm: a joint venture formed in 2006 — Ornamental Biosciences, Inc. — for the commercialization of ornamental crop varieties differentiated in the marketplace for improved growth and survival under a range of stresses.
- SweTree Technologies: a collaboration for the development of improved varieties of plantation forest tree species.
- ArborGen: a collaboration to improve stress tolerance in selected tree species.
People
Scientific advisory board
As of June 2010:[13]
- Dr. Elliot Meyerowitz
- Dr. Jonathan Jones
- Dr. Brian Staskawicz
- Dr. Fred Ausubel
- Dr. Ulrich Schirmer
- Dr. Andrew Millar
- Dr. Joseph R. Ecker
- Dr. Andrew H. Paterson
- Dr. Charles Wyman
Funding
Contact
As at July 2010:[14]
- Address: Mendel Biotechnology, 3935 Point Eden Way, Hayward, CA 94545
- Phone 510-264-0280
- Fax 510-264-0254
- http://www.Mendelbio.com
Resources
Notes
- ↑ Our mission, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Strategic partners, Mendel Biotechnology website, acc 8 Jul 2010
- ↑ Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
- ↑ Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
- ↑ Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
- ↑ Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
- ↑ Dear Shareholder, Mendel Biotechnology Annual Report 2009, p. 4, acc 8 Jul 2010
- ↑ Strategic partners, Mendel Biotechnology website, acc 8 Jul 2010
- ↑ Issued patents, Mendel Biotechnology website, acc 8 July 2010
- ↑ Mendel Biotechnology Annual Report 2008, p 4, acc 8 Jul 2010
- ↑ Strategic Partners, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Strategic Partners, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Scientific Advisory Board, Mendel Biotechnology website, acc 9 Jun 2010
- ↑ Mendel Biotechnology Annual Report 2009, acc 8 Jul 2010
